Amwill Health Care Limited (BOM:544353)
India · Delayed Price · Currency is INR 41.00
+0.99 (2.47%)
At close: Jul 28, 2026
Amwill Health Care Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 114.21 | 107.3 | 125 | 31.14 | 25.74 |
Depreciation & Amortization | 5.46 | 4.36 | 2.33 | 2.31 | 3.25 |
Other Amortization | - | 0.19 | 0.05 | 0.07 | 0.02 |
Loss (Gain) From Sale of Assets | 0.49 | - | -0.28 | - | 0.88 |
Provision & Write-off of Bad Debts | - | 0.53 | 0.01 | - | - |
Other Operating Activities | -23.96 | -11.59 | 0.13 | -0.54 | -2.67 |
Change in Accounts Receivable | -41.8 | -38.18 | -117.25 | -3.57 | 35.38 |
Change in Inventory | -3.4 | -1.4 | 26.46 | -11.22 | 4.37 |
Change in Accounts Payable | 13.29 | 8.2 | -48.92 | 27.52 | -26.37 |
Change in Other Net Operating Assets | 15.74 | -13.77 | -18.08 | 2.21 | -10.43 |
Operating Cash Flow | 80.03 | 55.64 | -30.55 | 47.92 | 30.18 |
Operating Cash Flow Growth | 43.83% | - | - | 58.77% | 4156.84% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -5.85 | -7.16 | -8.91 | -3.15 | -1.11 |
Sale of Property, Plant & Equipment | 0.5 | - | 0.57 | - | 0.5 |
Investment in Securities | -25.09 | -461.24 | -8.82 | -10.13 | - |
Other Investing Activities | 86.04 | 6.22 | 3.29 | 0.54 | 0.02 |
Investing Cash Flow | 55.6 | -462.17 | -13.87 | -12.74 | -0.59 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | - | - | 0.25 | 0.07 |
Total Debt Issued | - | - | - | 0.25 | 0.07 |
Short-Term Debt Repaid | - | - | -0.35 | -1.11 | -0.07 |
Total Debt Repaid | - | - | -0.35 | -1.11 | -0.07 |
Net Debt Issued (Repaid) | - | - | -0.35 | -0.86 | - |
Issuance of Common Stock | - | 488.8 | 0.2 | - | - |
Other Financing Activities | -0.59 | -75.53 | - | - | - |
Financing Cash Flow | -0.59 | 413.27 | -0.15 | -0.86 | - |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | 135.04 | 6.73 | -44.58 | 34.32 | 29.6 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 74.18 | 48.48 | -39.47 | 44.77 | 29.07 |
Free Cash Flow Growth | 53.01% | - | - | 53.99% | - |
Free Cash Flow Margin | 16.31% | 11.95% | -8.98% | 14.84% | 10.53% |
Free Cash Flow Per Share | 3.71 | 3.00 | -2.53 | 2.87 | 1.86 |
Levered Free Cash Flow | 61.04 | 23.84 | -59.91 | 37.74 | 20.07 |
Unlevered Free Cash Flow | 61.04 | 23.84 | -59.91 | 37.74 | 20.07 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Income Tax Paid | 34.85 | 17.02 | 39.88 | 9.98 | 10.25 |
Change in Working Capital | -16.17 | -45.15 | -157.79 | 14.94 | 2.96 |